Pancreatic cancer breakthrough as daily pill makes deadly tumours disappear in major trial




Its potential extends well beyond the pancreas.Dozens of other cancer types, including lung and ovarian, carry similar mutations, raising hopes that the treatment could eventually benefit a far wider group of patients.In the UK, more than 11,000 people receive a pancreatic cancer diagnosis annually, while upwards of 10,000 die from it each year.It carries the lowest survival rate of any common cancer in Britain.Researchers cautioned that cancer frequently develops resistance to drug therapies, and longer-term data remain essential before any conclusions about lasting remission can be drawn.